Related Experiment Videos
Novel antithrombotics based on modulation of the protein C pathway
1Division of Research Technologies and Proteins, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285-0444, USA.
Coronary Artery Disease
|July 1, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Substrate effect on thermal stability of superconductor thin films in the peritectic melting.
The journal of physical chemistry. B·2012
Use of vectors to confer resistance to antibiotics g418 and hygromycin in stably transfected cell lines.
Methods in molecular biology (Clifton, N.J.)·2011
Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alpha (activated).
Journal of thrombosis and haemostasis : JTH·2009
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.
Journal of thrombosis and haemostasis : JTH·2004
Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis.
Critical care medicine·2001
Amentoflavone and cancer: mechanistic insights and translational perspectives.
Frontiers in oncology·2026
What's in a Name? Etymology and History of Antibacterials and Antifungals.
Open forum infectious diseases·2026